title: Efalizumab-induced aseptic meningitis.
authors.forename: N
authors.initials: N
authors.lastname: Kluger
authors.forename: C
authors.initials: C
authors.lastname: Girard
authors.forename: V
authors.initials: V
authors.lastname: Gonzalez
authors.forename: B
authors.initials: B
authors.lastname: Guillot
authors.forename: D
authors.initials: D
authors.lastname: Bessis
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab